Aspen Aerogels Inc (NYSE:ASPN)’s traded shares stood at 2.5 million during the last session, with the company’s beta value hitting 2.15. At the close of trading, the stock’s price was $15.54, to imply a decrease of -1.65% or -$0.26 in intraday trading. The ASPN share’s 52-week high remains $33.15, putting it -113.32% down since that peak but still an impressive 43.44% since price per share fell to its 52-week low of $8.79. The company has a valuation of $1.28B, with an average of 3.34 million shares in intraday trading volume over the past 10 days and average of 2.43 million shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Aspen Aerogels Inc (ASPN), translating to a mean rating of 1.09. Of 10 analyst(s) looking at the stock, 0 analyst(s) give ASPN a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 9 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at 0.04.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Aspen Aerogels Inc (NYSE:ASPN) trade information
After registering a -1.65% downside in the last session, Aspen Aerogels Inc (ASPN) has traded red over the past five days. The 5-day price performance for the stock is -7.83%, and -30.75% over 30 days. With these gigs, the year-to-date price performance is -1.52%. Short interest in Aspen Aerogels Inc (NYSE:ASPN) saw shorts transact 8.51 million shares and set a 2.86 days time to cover.
The extremes give us $18 and $38 for target low and target high price respectively. As such, ASPN has been trading -144.53% off suggested target high and -15.83% from its likely low.
Aspen Aerogels Inc (ASPN) estimates and forecasts
Looking at statistics comparing Aspen Aerogels Inc share performance against respective industry, we note that the company has outperformed competitors. Aspen Aerogels Inc (ASPN) shares are -40.57% down over the last 6 months, with its year-to-date growth rate higher than industry average at 116.67% against 6.20%. Revenue is forecast to grow 500.00% this quarter before jumping 200.00% for the next one. The rating firms project that company’s revenue will grow 84.40% compared to the previous financial year.
Revenue forecast for the current quarter as set by 11 analysts is 113.85M. Meanwhile, for the current quarter, a total of 7 analyst(s) estimate revenue growth to 104.06M.Earnings reports from the last fiscal year show that sales brought in 84.22M and 75M respectively in the corresponding quarters. In this case, analysts estimate current quarter sales to rise 35.20% before jumping 38.70% in the following quarter.
ASPN Dividends
Aspen Aerogels Inc has its next earnings report out in December. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Aspen Aerogels Inc (NYSE:ASPN)’s Major holders
Aspen Aerogels Inc insiders hold 16.59% of total outstanding shares, with institutional holders owning 77.66% of the shares at 93.11% float percentage. In total, 77.66% institutions holds shares in the company, led by KIM, LLC. As of 2024-06-30, the company held over 12.28 million shares (or 16.209% of shares), all amounting to roughly $292.89 million.
The next major institution holding the largest number of shares is BLACKROCK INC. with 4.49 million shares, or about 5.9295% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $107.14 million.
